Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$36.08 - $54.3 $85,040 - $127,985
-2,357 Reduced 0.33%
706,492 $26.5 Million
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $24.3 Million - $40.8 Million
708,849 New
708,849 $39.7 Million
Q1 2020

May 15, 2020

BUY
$51.57 - $106.62 $2.95 Million - $6.09 Million
57,162 Added 113.92%
107,339 $6.69 Million
Q3 2019

Nov 14, 2019

BUY
$49.99 - $62.0 $2.51 Million - $3.11 Million
50,177 New
50,177 $2.53 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.